More than 60 years ago, Dr. Sidney Farber – the founder of what is now Dana-Farber/Boston Children's Cancer and Blood Disorders Center – refused to accept that childhood cancer was untreatable. His determination led to the development of chemotherapy and the first remissions of childhood leukemia. Today, Dana-Farber/Boston Children's continues Dr. Farber’s legacy through research that has yielded many of the advances in care used today.
View a list of our hematology and oncology research achievements on the Dana-Farber/Boston Children's website.
